| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
8,581 |
8,534 |
$785K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,362 |
6,448 |
$524K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,166 |
1,138 |
$104K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,917 |
1,803 |
$58K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
919 |
902 |
$11K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
166 |
159 |
$9K |
| 81025 |
|
1,565 |
1,498 |
$9K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,375 |
1,120 |
$9K |
| 99000 |
|
1,345 |
1,270 |
$4K |
| 81003 |
|
2,210 |
2,126 |
$3K |
| 71046 |
Radiologic examination, chest; 2 views |
121 |
115 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
344 |
334 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
345 |
316 |
$494.45 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
38 |
38 |
$384.08 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
13 |
13 |
$150.00 |
| 87807 |
|
16 |
15 |
$108.50 |
| 99072 |
|
3,515 |
3,302 |
$100.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
26 |
25 |
$13.70 |
| S9083 |
Global fee urgent care centers |
13 |
13 |
$0.00 |
| T1502 |
Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit |
262 |
258 |
$0.00 |